Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma

Clinical Immunology

Volumn 125, Issue 3, 2007, Pages 309-317

  Wei, Ye Sheng ^a   Lan, Yan ^a   Tang, Ren Guang ^a   Xu, Qun Qing ^a   Huang, Yan ^a   Nong, Hong Bing ^a   Huang, Wei Tong ^a  

^a YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

Author keywords

Haplotype; Interleukin 8; NPC; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 8;

ARTICLE; CANCER RISK; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CHINA; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 36148931394     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.07.010     Document Type: Article

References (56)

1. McDermott A.L., Dutt S.N., and Watkinson J.C. The aetiology of nasopharyngeal carcinoma. Clin. Otolaryngol. Allied Sci. 26 (2001) 82-92
2. Chen D.L., and Huang T.B. A case-control study of risk factors of nasopharyngeal carcinoma. Cancer Lett. 117 (1997) 17-22
3. Yu M.C., and Yuan J.M. Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol. 12 (2002) 421-429
4. Sriamporn S., Vatanasapt V., Pisani P., Yongchaiyudha S., and Rungpitarangsri V. Environmental risk factors for nasopharyngeal carcinoma: a case-control study in northeastern Thailand. Cancer Epidemiol., Biomarkers Prev. 1 (1992) 345-348
5. Zheng X., Yan L., Nilsson B., Eklund G., and Drettner B. Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. A case-control study in southern China. Acta Oncol. 33 (1994) 867-872
6. Cao Y., Miao X.P., Huang M.Y., Deng L., Hu L.F., Ernberg I., Zeng Y.X., Lin D.X., and Shao J.Y. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer 6 (2006) 167
7. Hirankarn N., Kimkong I., and Mutirangura A. HLA-E polymorphism in patients with nasopharyngeal carcinoma. Tissue Antigens 64 (2004) 588-592
8. Catarino R.J., Breda E., Coelho V., Pinto D., Sousa H., Lopes C., and Medeiros R. Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma. Head Neck 28 (2006) 603-608
9. Matsushima K. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1 (1989) 2-13
10. Matsushima K., Baldwin E.T., and Mukaida N. Interleukin-8 and MCAF: novel leukocyte recruitment and activity cytokines. Chem. Immunol. 51 (1992) 236-265
11. Wang J.M., Deng X., Gong W., and Su S. Chemokines and their role in tumor growth and metastasis. J. Immunol. Methods 220 (1998) 1-17
12. Liu J., Schuff-Werner P., and Steiner M. Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells. Biochem. Biophys. Res. Commun. 343 (2006) 183-189
13. Hidaka H., Ishiko T., Ishikawa S., Ikeda O., Mita S., Iwamura T., Chijiiwa K., and Ogawa M. Constitutive IL-8 expression in cancer cells is associated with mutation of p53. J. Exp. Clin. Cancer Res. 24 (2005) 127-133
14. Wigmore S.J., Maingay J.P., Fearon K.C., and Ross J.A. Endogenous production of IL-8 by human colorectal cancer cells and its regulation by cytokines. Int. J. Oncol. 18 (2001) 467-473
15. Du H., Bay B.H., Mahendran R., and Olivo M. Endogenous expression of interleukin-8 and interleukin-10 in nasopharyngeal carcinoma cells and the effect of photodynamic therapy. Int. J. Mol. Med. 10 (2002) 73-76
16. Tas F., Duranyildiz D., Oguz H., Camlica H., Yasasever V., and Topuz E. Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancer. Cancer Investig. 24 (2006) 492-496
17. Lokshin A.E., Winans M., Landsittel D., Marrangoni A.M., Velikokhatnaya L., Modugno F., Nolen B.M., and Gorelik E. Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer. Gynecol. Oncol. 102 (2006) 244-251
18. Kozlowski L., Zakrzewska I., Tokajuk P., and Wojtukiewicz M.Z. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Rocz. Akad. Med. Bialymst. 48 (2003) 82-84
19. Fey M.F., and Tobler A. An interleukin-8 (IL-8) cDNA clone identifies a frequent HindIII polymorphism. Hum. Genet. 91 (1993) 298
20. Heinzmann A., Ahlert I., Kurz T., Berner R., and Deichmann K.A. Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J. Allergy Clin. Immunol. 114 (2004) 671-676
21. Ross O.A., O'Neill C., Rea I.M., Lynch T., Gosal D., Wallace A., Curran M.D., Middleton D., and Gibson J.M. Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish. Hum. Immunol. 65 (2004) 340-346
22. Vairaktaris E., Yapijakis C., Serefoglou Z., Derka S., Vassiliou S., Nkenke E., Vylliotis A., Wiltfang J., Avgoustidis D., Critselis E., Neukam F.W., and Patsouris E. The interleukin-8 (- 251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur. J. Surg. Oncol. 33 (2007) 504-507
23. Snoussi K., Mahfoudh W., Bouaouina N., Ahmed S.B., Helal A.N., and Chouchane L. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum. Immunol. 67 (2006) 13-21
24. Taguchi A., Ohmiya N., Shirai K., Mabuchi N., Itoh A., Hirooka Y., Niwa Y., and Goto H. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol., Biomarkers Prev. 14 (2005) 2487-2493
25. Lee W.P., Tai D.I., Lan K.H., Li A.F., Hsu H.C., Lin E.J., Lin Y.P., Sheu M.L., Li C.P., Chang F.Y., Chao Y., Yen S.H., and Lee S.D. The - 251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin. Cancer Res. 11 (2005) 6431-6441
26. John S.W., Weitzner G., Rozen R., and Scriver C.R. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res. 19 (1991) 408
27. Lee E.B., Kim J.Y., Zhao J., Park M.H., and Song Y.W. Haplotype association of IL-8 gene with Behcet's disease. Tissue Antigens 69 (2007) 128-132
28. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15 (2005) 97-98
29. Stephens M., Smith M.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68 (2001) 978-989
30. Ito H., Matsuo K., Hamajima N., Okuma K., Saito T., and Tajima K. Significant association of interleukin 8 - 251 T/A polymorphism with smoking behavior in a Japanese population. J. Hum. Genet. 50 (2005) 567-573
31. Jiang Z.D., Okhuysen P.C., Guo D.C., He R., King T.M., DuPont H.L., and Milewicz D.M. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J. Infect. Dis. 188 (2003) 506-511
32. Cooke G.S., Campbell S.J., Fielding K., Sillah J., Manneh K., Sirugo G., Bennett S., McAdam K.P., Lienhardt C., and Hill A.V. Interleukin-8 polymorphism is not associated with pulmonary tuberculosis in the Gambia. J. Infect. Dis. 189 (2004) 1545-1546
33. Savage S.A., Hou L., Lissowska J., Chow W.H., Zatonski W., Chanock S.J., and Yeager M. Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol., Biomarkers Prev. 15 (2006) 589-591
34. Renzoni E., Lympany P., Sestini P., Pantelidis P., Wells A., Black C., Welsh K., Bunn C., Knight C., Foley P., du R., and Bois M. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum. 43 (2000) 1633-1640
35. Lu H., Ouyang W., and Huang C. Inflammation, a key event in cancer development. Mol. Cancer Res. 4 (2006) 221-233
36. Moss S.F., and Blaser M.J. Mechanisms of disease: inflammation and the origins of cancer. Nat. Clin. Pract. Oncol. 2 (2005) 90-97
37. Quirk J.T., and Kupinski J.M. Chronic infection, inflammation, and epithelial ovarian cancer. Med. Hypotheses 57 (2001) 426-428
38. Lin W.W., and Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117 (2007) 1175-1183
39. Rollins B.J. Inflammatory chemokines in cancer growth and progression. Eur. J. Cancer 42 (2006) 760-767
40. Yoshizaki T., Horikawa T., Qing-Chun R., Wakisaka N., Takeshita H., Sheen T.S., Lee S.Y., Sato H., and Furukawa M. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin. Cancer Res. 7 (2001) 1946-1951
41. Wang Y., Yang J., Gao Y., Du Y., Bao L., Niu W., and Yao Z. Regulatory effect of e2, IL-6 and IL-8 on the growth of epithelial ovarian cancer cells. Cell Mol. Immunol. 2 (2005) 365-372
42. Mizukami Y., Jo W.S., Duerr E.M., Gala M., Li J., Zhang X., Zimmer M.A., Iliopoulos O., Zukerberg L.R., Kohgo Y., Lynch M.P., Rueda B.R., and Chung D.C. Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat. Med. 11 (2005) 992-997
43. Boldrini L., Gisfredi S., Ursino S., Lucchi M., Mussi A., Basolo F., Pingitore R., and Fontanini G. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations. Lung Cancer 50 (2005) 309-317
44. Zhang W., Stoehlmacher J., Park D.J., Yang D., Borchard E., Gil J., Tsao-Wei D.D., Yun J., Gordon M., Press O.A., Rhodes K., Groshen S., and Lenz H.J. Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer. Clin. Colorectal Cancer 5 (2005) 124-131
45. Itoh Y., Joh T., Tanida S., Sasaki M., Kataoka H., Itoh K., Oshima T., Ogasawara N., Togawa S., Wada T., Kubota H., Mori Y., Ohara H., Nomura T., Higashiyama S., and Itoh M. IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. Cytokine 29 (2005) 275-282
46. Uslu R., Sanli U.A., Dikmen Y., Karabulut B., Ozsaran A., Sezgin C., Muezzinoglu G.G., Omay S.B., and Goker E. Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens. Int. J. Gynecol. Cancer 15 (2005) 240-245
47. Gokhale A.S., Haddad R.I., Cavacini L.A., Wirth L., Weeks L., Hallar M., Faucher J., and Posner M.R. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck. Oral Oncol. 41 (2005) 70-76
48. Lehrer S., Diamond E.J., Mamkine B., Stone N.N., and Stock R.G. Serum interleukin-8 is elevated in men with prostate cancer and bone metastases. Technol. Cancer Res. Treat. (2004) 411
49. Ohyauchi M., Imatani A., Yonechi M., Asano N., Miura A., Iijima K., Koike T., Sekine H., Ohara S., and Shimosegawa T. The polymorphism interleukin 8 - 251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 54 (2005) 330-335
50. Lu W., Pan K., Zhang L., Lin D., Miao X., and You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 26 (2005) 631-636
51. Shirai K., Ohmiya N., Taguchi A., Mabuchi N., Yatsuya H., Itoh A., Hirooka Y., Niwa Y., Mori N., and Goto H. Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability. J. Gastroenterol. Hepatol. 21 (2006) 1129-1135
52. Kamangar F., Abnet C.C., Hutchinson A.A., Newschaffer C.J., Helzlsouer K., Shugart Y.Y., Pietinen P., Dawsey S.M., Albanes D., Virtamo J., and Taylor P.R. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 17 (2006) 117-125
53. Yang H.P., Woodson K., Taylor P.R., Pietinen P., Albanes D., Virtamo J., and Tangrea J.A. Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial. Eur. J. Cancer Prev. 15 (2006) 249-253
54. Michaud D.S., Daugherty S.E., Berndt S.I., Platz E.A., Yeager M., Crawford E.D., Hsing A., Huang W.Y., and Hayes R.B. Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res. 66 (2006) 4525-4530
55. Snoussi K., Mahfoudh W., Bouaouina N., Ahmed S.B., Helal A.N., and Chouchane L. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum. Immunol. 67 (2006) 13-21
56. Smith K.C., Bateman A.C., Fussell H.M., and Howell W.M. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur. J. Immunogenet. 31 (2004) 167-173